X-51895058-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_006986.4(MAGED1):āc.51G>Cā(p.Glu17Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000005 in 1,199,740 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006986.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAGED1 | NM_006986.4 | c.51G>C | p.Glu17Asp | missense_variant | 3/13 | ENST00000326587.12 | NP_008917.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAGED1 | ENST00000326587.12 | c.51G>C | p.Glu17Asp | missense_variant | 3/13 | 1 | NM_006986.4 | ENSP00000325333 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00000893 AC: 1AN: 111928Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34086
GnomAD4 exome AF: 0.00000460 AC: 5AN: 1087812Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 355036
GnomAD4 genome AF: 0.00000893 AC: 1AN: 111928Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34086
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 27, 2022 | The c.219G>C (p.E73D) alteration is located in exon 4 (coding exon 3) of the MAGED1 gene. This alteration results from a G to C substitution at nucleotide position 219, causing the glutamic acid (E) at amino acid position 73 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at